Eli Lilly (LLY ... the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Lilly holds industry-leading growth potential as the company is launching several new blockbusters and patent losses are fading. We’re maintaining our $580 fair value estimate for Eli Lilly and ...

Eli Lilly's orforglipron's highest 36 mg dose ... The bottom line: We're maintaining our $650 Lilly fair value estimate as we await further orforglipron data in obesity patients in the third ...